Published in Yale J Biol Med on February 15, 1985
Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins. Infect Immun (1990) 4.10
Detailed analysis of sequence changes occurring during vlsE antigenic variation in the mouse model of Borrelia burgdorferi infection. PLoS Pathog (2009) 1.24
Effects of vlsE complementation on the infectivity of Borrelia burgdorferi lacking the linear plasmid lp28-1. Infect Immun (2004) 1.22
Lymphocytic meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: a clinical and serological study of 18 cases. J Neurol Neurosurg Psychiatry (1987) 1.17
Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice. Infect Immun (2003) 1.02
Delays and diversions mark the development of B cell responses to Borrelia burgdorferi infection. J Immunol (2012) 0.99
The amber theory of Lyme arthritis: initial description and clinical implications. Clin Rheumatol (2012) 0.97
Detection of immune complexes is not independent of detection of antibodies in Lyme disease patients and does not confirm active infection with Borrelia burgdorferi. Clin Diagn Lab Immunol (2005) 0.84
Murine model for lymphocytic tropism by Borrelia burgdorferi. Infect Immun (2001) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A. J Immunol (1975) 47.77
Lyme disease-a tick-borne spirochetosis? Science (1982) 27.50
The spirochetal etiology of Lyme disease. N Engl J Med (1983) 21.59
Enzyme immunoassays in diagnostic medicine. Theory and practice. Bull World Health Organ (1976) 12.01
Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med (1983) 11.15
Cultivation of Borrelia hermsi. Science (1971) 6.83
Fluorescent treponemal antibody-absorption (FTA-ABS) test for syphilis. JAMA (1966) 4.75
Antibody response in Lyme disease: evaluation of diagnostic tests. J Infect Dis (1984) 4.07
Neurologic abnormalities of Lyme disease. Medicine (Baltimore) (1979) 3.98
Lyme arthritis: correlation of serum and cryoglobulin IgM with activity, and serum IgG with remission. Arthritis Rheum (1979) 1.70
The spirochetal etiology of Lyme disease. N Engl J Med (1983) 21.59
Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. Arthritis Rheum (1977) 9.14
Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med (1977) 7.42
Western blotting in the serodiagnosis of Lyme disease. J Infect Dis (1993) 6.45
The early clinical manifestations of Lyme disease. Ann Intern Med (1983) 5.73
Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. J Clin Invest (1986) 5.72
Cases of Lyme disease in the United States: locations correlated with distribution of Ixodes dammini. Ann Intern Med (1979) 4.73
Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med (1980) 4.12
Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. J Clin Invest (1983) 4.08
Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease. J Infect Dis (1988) 4.08
Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med (1994) 4.07
Antibody response in Lyme disease: evaluation of diagnostic tests. J Infect Dis (1984) 4.07
Neurologic abnormalities of Lyme disease. Medicine (Baltimore) (1979) 3.98
Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science (1998) 3.68
The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology (1985) 3.55
Chronic neurologic manifestations of Lyme disease. N Engl J Med (1990) 3.54
Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J Clin Microbiol (1999) 3.41
The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med (1994) 3.20
Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun (1993) 3.04
Experimental Lyme arthritis in rats infected with Borrelia burgdorferi. J Infect Dis (1988) 3.02
From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol (2001) 3.02
Antibiotic therapy in Lyme disease. Ann Intern Med (1980) 2.93
A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. Science (1986) 2.91
Treatment of the early manifestations of Lyme disease. Ann Intern Med (1983) 2.89
DNA characterization of the spirochete that causes Lyme disease. J Clin Microbiol (1984) 2.71
Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection. Infect Immun (1994) 2.57
Erythema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick vector. Am J Epidemiol (1978) 2.53
Empiric parenteral antibiotic treatment of patients with fibromyalgia and fatigue and a positive serologic result for Lyme disease. A cost-effectiveness analysis. Ann Intern Med (1993) 2.52
Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. Ann Intern Med (1983) 2.50
Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med (1997) 2.48
Diagnosing early Lyme disease. Am J Med (1985) 2.41
Handwashing practices for the prevention of nosocomial infections. Ann Intern Med (1975) 2.36
Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med (2001) 2.34
Identification of Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9-kilobase-pair subfragment of the genome. Proc Natl Acad Sci U S A (1984) 2.32
Successful parenteral penicillin therapy of established Lyme arthritis. N Engl J Med (1985) 2.23
Possible nosocomial transmission of group B streptococci in a newborn nursery. J Pediatr (1975) 2.21
Treatment of early Lyme disease. Am J Med (1992) 2.18
Genome of a mononucleosis Epstein-Barr virus contains DNA fragments previously regarded to be unique to Burkitt's lymphoma isolates. Cell (1981) 2.17
Clinical pathologic correlations of Lyme disease by stage. Ann N Y Acad Sci (1988) 2.16
Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet (1993) 2.05
Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis. Demonstration of spirochetes in the myocardium. Ann Intern Med (1985) 2.04
Lyme arthritis. Spirochetes found in synovial microangiopathic lesions. Am J Pathol (1985) 2.03
Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. Arthritis Rheum (1999) 2.01
Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J Clin Microbiol (1999) 1.95
Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in alpha beta(+) T cells. Nature (1994) 1.94
High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452. Am J Pathol (1988) 1.86
Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin Infect Dis (2000) 1.82
Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. Ann Intern Med (1979) 1.79
The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect Immun (1999) 1.79
Chronic Lyme arthritis. Clinical and immunogenetic differentiation from rheumatoid arthritis. Ann Intern Med (1979) 1.79
The T-cell proliferative assay in the diagnosis of Lyme disease. Ann Intern Med (1991) 1.70
Lyme arthritis: correlation of serum and cryoglobulin IgM with activity, and serum IgG with remission. Arthritis Rheum (1979) 1.70
The clinical spectrum and treatment of Lyme disease. Yale J Biol Med (1985) 1.70
Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease. Infect Immun (1995) 1.68
The long-term course of Lyme arthritis in children. N Engl J Med (1991) 1.63
Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers. Proc Natl Acad Sci U S A (2000) 1.61
An animal model for Lyme arthritis. Ann N Y Acad Sci (1988) 1.60
Expression in COS-1 cells of Epstein-Barr virus nuclear antigen from a complete gene and a deleted gene. J Virol (1984) 1.57
Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population. J Infect Dis (1986) 1.56
Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection. J Immunol (1998) 1.53
Immune complexes and the evolution of Lyme arthritis. Dissemination and localization of abnormal C1q binding activity. N Engl J Med (1979) 1.53
Lyme disease. Adv Intern Med (1995) 1.49
Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin Infect Dis (2001) 1.45
Recovery of Lyme disease spirochetes from patients. Yale J Biol Med (1985) 1.42
Pseudomonas species bacteremia caused by contaminated normal human serum albumin. J Infect Dis (1977) 1.42
Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis. J Infect Dis (1994) 1.41
The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. J Exp Med (1994) 1.41
Serodiagnosis of early Lyme disease: analysis of IgM and IgG antibody responses by using an antibody-capture enzyme immunoassay. J Infect Dis (1988) 1.39
Elevated levels of collagenase and prostaglandin E2 from synovium associated with erosion of cartilage and bone in a patient with chronic Lyme arthritis. Arthritis Rheum (1980) 1.38
T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J Immunol (1998) 1.35
Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease. Infect Immun (2001) 1.32
Constitutive expression of Epstein-Barr virus-encoded RNAs and nuclear antigen during latency and after induction of Epstein-Barr virus replication. J Virol (1985) 1.32
Proliferative responses of mononuclear cells in Lyme disease. Reactivity to Borrelia burgdorferi antigens is greater in joint fluid than in blood. Arthritis Rheum (1986) 1.31
Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum (1999) 1.27
Arthritis caused by Borrelia burgdorferi in dogs. J Am Vet Med Assoc (1985) 1.26
Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays. J Clin Invest (1979) 1.26
Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist. J Clin Invest (1992) 1.26
[Spirochete etiology of erythema chronicum migrans disease]. Dtsch Med Wochenschr (1984) 1.23
Neurological findings of Lyme disease. Yale J Biol Med (1985) 1.21
Infectivity of Borrelia burgdorferi correlates with resistance to elimination by phagocytic cells. J Infect Dis (1991) 1.21
Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans. J Invest Dermatol (2000) 1.20
Lyme disease associated with fibromyalgia. Ann Intern Med (1992) 1.18
Towards the measurement of community participation. World Health Forum (1989) 1.18
Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis (1996) 1.17
Anticardiolipin antibodies in Lyme disease. Arthritis Rheum (1988) 1.16
Antibody responses to two Epstein-Barr virus nuclear antigens defined by gene transfer. N Engl J Med (1985) 1.14